Sanhome is a private owned pharmaceutical company focusing on drug innovation. Sanhome was founded in 1996 and is based in mainland China. Sanhome is focusing on the innovation of both small molecules and monoclonal antibodies for oncology, infectious diseases and neurodegeneration, with nearly 400 scientists in R&D Centre. Sanhome has a GMP level manufacturing line, and has more than 1000 employees in marketing and sales team spreading all over mainland China (only except Tibet). I have been trained in Peking University, followed by a Ph.D. training in neuroscience and pharmacology in Cardiff University, UK. After 3.5 years post-doc research in Dalhousie University, Canada, I have joined Sanhome in 2016. Currently, I am leading a research team to develop new molecules for Alzheimer's disease, and I am in charge of all the pharmacology work in neuroscience field as the Deputy pharmacology director. Meanwhile, I am dealing with all the licensing in/out and collaboration for research projects as the Deputy BD director.